The stock of Invivyd Inc (IVVD) has gone up by 45.60% for the week, with a 65.90% rise in the past month and a -46.64% drop in the past quarter. The volatility ratio for the week is 24.69%, and the volatility levels for the past 30 days are 13.67% for IVVD. The simple moving average for the past 20 days is 38.64% for IVVD’s stock, with a -1.16% simple moving average for the past 200 days.
Is It Worth Investing in Invivyd Inc (NASDAQ: IVVD) Right Now?
Moreover, the 36-month beta value for IVVD is 0.41. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for IVVD is 75.94M and currently, short sellers hold a 9.92% of that float. On May 13, 2025, IVVD’s average trading volume was 3.63M shares.
IVVD) stock’s latest price update
Invivyd Inc (NASDAQ: IVVD)’s stock price has gone rise by 29.67 in comparison to its previous close of 0.65, however, the company has experienced a 45.60% increase in its stock price over the last five trading days. globenewswire.com reported 2025-05-12 that WALTHAM, Mass., May 12, 2025 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD) today announced it has initiated a discovery program for a measles monoclonal antibody (mAb). Multiple healthcare providers (HCPs) who are treating active measles and monitoring contacts and outbreaks have inquired directly to Invivyd about the possibility of accessing such a medicine, as there are no currently approved therapies for measles or for post-exposure prophylaxis. Measles monoclonal neutralizing antibody discovery efforts would join current Invivyd discovery programs for next-generation COVID-19, respiratory syncytial virus (RSV), and influenza mAbs designed to treat acute infection or provide a high-quality alternative to vaccination.
Analysts’ Opinion of IVVD
Many brokerage firms have already submitted their reports for IVVD stocks, with Guggenheim repeating the rating for IVVD by listing it as a “Buy.” The predicted price for IVVD in the upcoming period, according to Guggenheim is $9 based on the research report published on April 05, 2024 of the previous year 2024.
Morgan Stanley, on the other hand, stated in their research note that they expect to see IVVD reach a price target of $10, previously predicting the price at $4. The rating they have provided for IVVD stocks is “Overweight” according to the report published on March 26th, 2024.
Morgan Stanley gave a rating of “Equal-Weight” to IVVD, setting the target price at $4 in the report published on December 19th of the previous year.
IVVD Trading at 24.12% from the 50-Day Moving Average
After a stumble in the market that brought IVVD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -69.42% of loss for the given period.
Volatility was left at 13.67%, however, over the last 30 days, the volatility rate increased by 24.69%, as shares surge +52.60% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -27.78% lower at present.
During the last 5 trading sessions, IVVD rose by +45.60%, which changed the moving average for the period of 200-days by -37.48% in comparison to the 20-day moving average, which settled at $0.6043. In addition, Invivyd Inc saw 89.08% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at IVVD starting from MCGUIRE TERRANCE, who sale 103,474 shares at the price of $0.45 back on Dec 31 ’24. After this action, MCGUIRE TERRANCE now owns 3,066,757 shares of Invivyd Inc, valued at $46,098 using the latest closing price.
MCGUIRE TERRANCE, the Director of Invivyd Inc, sale 83,744 shares at $0.52 during a trade that took place back on Dec 27 ’24, which means that MCGUIRE TERRANCE is holding 3,256,776 shares at $43,647 based on the most recent closing price.
Stock Fundamentals for IVVD
Current profitability levels for the company are sitting at:
- -6.97 for the present operating margin
- 0.92 for the gross margin
The net margin for Invivyd Inc stands at -6.69. The total capital return value is set at -2.62. Equity return is now at value -138.71, with -94.75 for asset returns.
Based on Invivyd Inc (IVVD), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -130.74.
Currently, EBITDA for the company is -173.76 million with net debt to EBITDA at 0.39. When we switch over and look at the enterprise to sales, we see a ratio of 1.28. The receivables turnover for the company is 2.27for trailing twelve months and the total asset turnover is 0.2. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.62.
Conclusion
To wrap up, the performance of Invivyd Inc (IVVD) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
